Cancer Clinical Trials Save State €6.5 Million in Drug Costs, Charity Says
Published
A new report from a cancer charity says that the Irish State has saved €6.51 million in drug costs because of cancer clinical trials. The figure is based on a sample of 38 trials that took place over the last 12 months. Clinical trials are research studies that test new treatments, such as medicines, on patients to see whether they are safe and effective.
The charity says that patients taking part in these trials can receive new drugs that are not yet widely available. In some cases, this means the State does not have to pay for those treatments during the study period. This is one reason why the charity believes trials can reduce costs for the health service while giving patients access to newer medicines.
The charity is calling for more investment in clinical trials in Ireland. It argues that more trials would help patients get access to modern cancer care and could bring further savings to the public health system in the future. The report is based only on a sample of trials, so the total savings across all trials may be different.
Cancer remains one of the most common causes of illness in Ireland, and the cost of new medicines is a growing concern for the health service. The findings add to the discussion about how the State can balance patient access to treatment with the need to control spending.
Sources: RTE.ie
More Ireland news
- Former Silicon Valley Insider Warns US Tech Giants Could Erase Ireland's Gains
- AI Creates New Cybersecurity Opportunities for Irish IT Firms, Research Finds
- Dublin Conference to Address Tech-Facilitated Sexual Violence
- Influencer Boxing Event in Kilkenny Ends in Chaos, Raising Concerns for Tourism
- Nearly 50 European Leaders Gather in Dublin for Major Summit
- Major Traffic Disruption Expected in Dublin as EU-Led Summits Approach
- Plans to Charge Asylum Seekers for Accommodation Delayed as Committee Calls for Contract Review
- Sinn Féin Calls for Referendum on State Pension Triple Lock